Jul 17, 2026 04:05PM
Jul 6, 2026 04:01PM
Jul 6, 2026 04:01PM
Jun 26, 2026 08:01AM
Jun 26, 2026 08:00AM
Jun 25, 2026 08:03AM
Jun 25, 2026 08:00AM Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
Jun 16, 2026 08:00AM
Jun 8, 2026 08:00AM
Jun 1, 2026 08:18AM
May 19, 2026 04:01PM
May 19, 2026 04:01PM
May 7, 2026 04:05PM
Apr 23, 2026 04:30PM Vaxart appoints James Breitmeyer to board of directors
Apr 23, 2026 04:30PM
Apr 17, 2026 08:31AM
Apr 17, 2026 08:30AM
Mar 12, 2026 04:05PM
Jan 15, 2026 08:00AM
Nov 13, 2025 04:05PM
Nov 5, 2025 04:00PM Dynavax licenses Vaxart's oral COVID-19 vaccine for $25 million upfront
Nov 5, 2025 04:00PM
Sep 10, 2025 04:55PM
Sep 10, 2025 04:54PM
Aug 13, 2025 04:05PM
Jun 11, 2025 07:30AM
Jun 11, 2025 07:30AM
May 27, 2025 08:00AM Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
May 15, 2025 08:01AM
May 15, 2025 08:00AM
May 14, 2025 04:05PM
May 13, 2025 04:05PM
May 13, 2025 04:02PM
May 13, 2025 04:01PM
Apr 30, 2025 08:01AM Vaxart (VXRT) Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
Apr 30, 2025 08:00AM
Mar 20, 2025 04:01PM
Mar 11, 2025 08:00AM
Mar 5, 2025 04:06PM
Mar 5, 2025 04:05PM
Jan 28, 2025 08:02AM
Jan 28, 2025 08:00AM Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors
Jan 14, 2025 08:07AM
Jan 14, 2025 08:00AM
Jan 13, 2025 07:55PM
Dec 2, 2024 04:01PM
Nov 13, 2024 04:01PM
Sep 30, 2024 04:12PM
Aug 28, 2024 08:01AM Vaxart (VXRT) Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dys
Aug 28, 2024 08:00AM

325,894 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All